fbpx
COVID-19 NewsNEWSLETTER

WHO Approves Two New COVID-19 Treatments

Only 1% Of Lagos Residents Got 2nd COVID-19 Vaccine - Sanwo-Olu

The World Health Organization has approved two new Covid-19 treatments on Friday, increasing the arsenal of tools alongside vaccines to keep off severe illness and death from the virus.

The information comes as Omicron cases fill hospitals around the world with the WHO predicting half of Europe will be infected by March.

WHO experts said arthritis drug baricitinib used with corticosteroids to treat severe or critical Covid patients led to better survival rates and reduced need for ventilators.

Experts also recommended synthetic antibody treatment Sotrovimab for people with non-serious Covid at highest risk of hospitalization, such as the elderly, people with immunodeficiencies or chronic diseases such as diabetes.

Sotrovimab’s benefits for people not at risk of hospitalization were deemed insignificant and the WHO said its effectiveness against new variants like Omicron was “still uncertain”.

Only three other treatments for Covid-19 have received WHO approval, starting with corticosteroids for severely ill patients in September 2020.

Corticosteroids are inexpensive and widely available and fight inflammation that commonly accompanies severe cases.

Arthritis drugs tocilizumab and sarilumab, which the WHO endorsed in July, are IL-6 inhibitors that suppress a dangerous overreaction of the immune system to the SARS-CoV-2 virus.

Synthetic antibody treatment Regeneron was approved by the WHO in September and the guidelines say Sotrovimab can be used for the same type of patients.

About Author

Boluwatife Oshadiya Lagos, Nigeria
Boluwatife Oshadiya is a graduate of Mass communication with a passion for content creation and digital marketing. He aspires to become a very well known and respected member of his field of study and can be reached via [email protected]

Comment here

This site uses Akismet to reduce spam. Learn how your comment data is processed.